These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18435811)

  • 21. Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
    Burger M; van der Aa MN; van Oers JM; Brinkmann A; van der Kwast TH; Steyerberg EC; Stoehr R; Kirkels WJ; Denzinger S; Wild PJ; Wieland WF; Hofstaedter F; Hartmann A; Zwarthoff EC
    Eur Urol; 2008 Oct; 54(4):835-43. PubMed ID: 18166262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
    Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
    BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive urothelial neoplasms: according to the most recent WHO classification.
    Lopez-Beltran A; Montironi R
    Eur Urol; 2004 Aug; 46(2):170-6. PubMed ID: 15245809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of grade of urothelial carcinoma according to WHO 2004 classification].
    Kruslin B; Belicza M
    Lijec Vjesn; 2006; 128(7-8):201-6. PubMed ID: 17087133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer.
    Mhawech-Fauceglia P; Ali L; Cheney RT; Groth J; Herrmann FR
    J Clin Pathol; 2009 Aug; 62(8):710-4. PubMed ID: 19638542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [So-called "superficial" bladder tumors. Which classification in 2003? Part 1: Papillary tumors].
    Billerey C; Sibony M
    Ann Pathol; 2003 Feb; 23(1):21-33. PubMed ID: 12743497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.
    Denzinger S; Burger M; Fritsche HM; Bertz S; Hofstädter F; Wieland WF; Hartmann A; Otto W
    Scand J Urol Nephrol; 2009; 43(4):282-7. PubMed ID: 19382004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World Health Organization histologic classification: an independent prognostic factor in resected thymomas.
    Rena O; Papalia E; Maggi G; Oliaro A; Ruffini E; Filosso P; Mancuso M; Novero D; Casadio C
    Lung Cancer; 2005 Oct; 50(1):59-66. PubMed ID: 16009453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy.
    Resorlu B; Beduk Y; Baltaci S; Ergun G; Talas H
    BJU Int; 2009 Feb; 103(4):480-3. PubMed ID: 18990160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
    J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.
    Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI
    Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.
    Mamoon N; Iqbal MA; Jamal S; Luqman M
    J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.